Metabolomics Workbench : NIH Data Repository

Clustering data with heatmap algorithm for (Study ST003412)

This analysis uses the 'heatmap.2' function of gplots package in the R statistics environment

The rows are scaled to have mean=0 and standard deviation=1

Factors:

F1	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:0.5 uM cerulenin
F2	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:2.0 uM cerulenin
F3	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:20 uM cerulenin
F4	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:4.0 uM cerulenin
F5	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:50 uM cerulenin
F6	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:cerulenin \| Drug Treatment:6.0 uM cerulenin
F7	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:NA \| Drug Treatment:Control
F8	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:1 nM TVB-2640
F9	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:200 nM TVB-2640
F10	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:20 nM TVB-2640
F11	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:500 nM TVB-2640
F12	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:50 nM TVB-2640
F13	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-2640 \| Drug Treatment:5 uM TVB-2640
F14	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:1 nM TVB-3166
F15	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:200 nM TVB-3166
F16	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:20 nM TVB-3166
F17	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:500 nM TVB-3166
F18	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:50 nM TVB-3166
F19	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug:TVB-3166 \| Drug Treatment:5 uM TVB-3166
F20	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:0.5 uM cerulenin
F21	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:2.0 uM cerulenin
F22	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:20 uM cerulenin
F23	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:4.0 uM cerulenin
F24	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:50 uM cerulenin
F25	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:cerulenin \| Drug Treatment:6.0 uM cerulenin
F26	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:NA \| Drug Treatment:Control
F27	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:1 nM TVB-2640
F28	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:200 nM TVB-2640
F29	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:20 nM TVB-2640
F30	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:500 nM TVB-2640
F31	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:50 nM TVB-2640
F32	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-2640 \| Drug Treatment:5 uM TVB-2640
F33	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:1 nM TVB-3166
F34	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:200 nM TVB-3166
F35	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:20 nM TVB-3166
F36	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:500 nM TVB-3166
F37	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:50 nM TVB-3166
F38	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug:TVB-3166 \| Drug Treatment:5 uM TVB-3166
F39	Sample source:NA \| Sample Type:Blank \| Drug:- \| Drug Treatment:NA
F40	Sample source:NA \| Sample Type:Blank \| Drug:NA \| Drug Treatment:NA
F41	Sample source:NA \| Sample Type:Medium \| Drug:NA \| Drug Treatment:NA
F42	Sample source:NA \| Sample Type:QC \| Drug:- \| Drug Treatment:NA
F43	Sample source:NA \| Sample Type:QC \| Drug:NA \| Drug Treatment:NA

Data matrix